Features
The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens to pull the rug from under...
The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating collaboration and...
The 25th May 2018 will be a critically important date for the UK - pharmaceutical companies will immediately recognize it as the inauguration of...
September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark the occasion,...
Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns and Advocacy Officer at...
Fiona Stevens, Partner at Gill, Jennings and Every, discusses the UK Supreme Court's decision on Eli Lilly v Actavis [2017] UKSC 48, and why...
Pivotal moment for the relationship between Donald Trump and industry, as MSD CEO Kenneth Frazier leads the collapse of the President's...
Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid...
Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives his work in rare diseases.
British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough...
